Video

Visual outcomes of small-aperture IOL implant in post-laser refractive eyes

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|AAO

Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.


Robert Ang, MD, director, Refractive Surgery Department, Asian Eye Institute (Philippines), discusses highlights of his AAO 2020 presentation on a study titled, "Visual outcomes of small-aperture IOL implantation in post-laser refractive eyes."

See more AAO coverage

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
(Image credit: AdobeStock/racesy) Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
September 3rd 2025

Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting

3 Things You Should Know About the GA Pipeline
September 3rd 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Next-generation IOLs advance complex cataract care
September 3rd 2025

Next-generation IOLs advance complex cataract care

3 Things You Should Know About the GA Pipeline
September 3rd 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

The emerging era of presbyopia-correcting eye drops: What’s next?
September 3rd 2025

The emerging era of presbyopia-correcting eye drops: What’s next?

(Image credit: SeeWhatMatters)
September 3rd 2025

Q&A: AEVR's executive director on #SeeWhatMatters and safeguarding the National Eye Institute

© 2025 MJH Life Sciences

All rights reserved.